Tag: AB-101

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to AB-101

Earnings call: Arbutus Biopharma outlines progress in HBV clinical trials - Investing.com

Added to Collection on: 2024-05-03 10:06:41

Tags for this article:

Orphan drugs
Antineoplastic drugs
Immune system
Clusters of differentiation
Monoclonal antibodies
Arbutus Biopharma
Durvalumab
Checkpoint inhibitor
Hepatitis B
PD-L1
Nivolumab
Programmed cell death protein 1
Arbutus Biopharma Corp
Mike McElhaugh
AB-101
Karen Sims

Click the tags to see associated articles and topics

View Article Details
Earnings call: Arbutus Biopharma reports progress in hepatitis B treatment - Investing.com

Added to Collection on: 2024-08-01 20:57:57

Tags for this article:

Infectious causes of cancer
Antiviral drugs
Hepatitis B
Hepatitis
HBsAg
Interferon
Nivolumab
Arbutus Biopharma
George Lau
AB-101
Michael McElhaugh

Click the tags to see associated articles and topics

View Article Details
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2024 Earnings Call Transcript

Added to Collection on: 2024-08-02 17:06:07

Tags for this article:

Infectious causes of cancer
Antiviral drugs
Cytokines
Hepatitis B
Hepatitis
Interferon
Arbutus Biopharma
HBsAg
Nivolumab
George Lau
AB-101
Michael McElhaugh
Arbutus Biopharma Corporation
Dave Hastings
David Hastings

Click the tags to see associated articles and topics

View Article Details
Arbutus Announces Four Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2025

Added to Collection on: 2025-10-07 16:10:17

Tags for this article:

Clusters of differentiation
Infectious causes of cancer
Hepadnaviridae
Hepatitis B virus
Hepatitis B
Viral hepatitis
Arbutus Biopharma
Hepatitis
HBsAg
Programmed cell death protein 1
PD-L1
Liver cancer
AB-101
Arbutus Biopharma Corporation

Click the tags to see associated articles and topics

View Article Details
Book a Demo